Lonza to manufacture Intellect Neurosciences drug; Scammers go after Internet drug buyers;

> India has put new price controls on nearly 350 drugs, up from the 74 that had limits. Story

> Drugmakers are now owed between $15.4 billion and $19.5 billion by European countries that have yet to pay their pharma bills. Story

> Intellect Neurosciences plans to have Lonza manufacture its new antibody-drug conjugate Conjumab-A. Item

> Indian API maker Cadila Pharmaceutical says one of its employees working with its pharmaceutical division has been arrested for embezzlement. Story

> While the diabetes drug metformin holds potential as a cheap and effective treatment against some cancers, drugmakers are reluctant to invest in research for a drug already off patent. Story

And Finally... The FDA is investigating reports that scammers are calling people who have purchased drugs from Internet pharmacies and threatening them if they don't pay fines. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.